FRESENIUS MEDICAL CARE AG Transaction Price Allocated To Remaining Performance Obligations
FRESENIUS MEDICAL CARE AG (FMS) had Transaction Price Allocated To Remaining Performance Obligations of EUR 771.30 million as of 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Notes
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations · last filed 2026-02-24
- 2025-12-31: Transaction Price Allocated To Remaining Performance Obligations 771.30M EUR.
- 2024-12-31: Transaction Price Allocated To Remaining Performance Obligations 697.62M EUR.
- 2023-12-31: Transaction Price Allocated To Remaining Performance Obligations 858.08M EUR.
- 2022-12-31: Transaction Price Allocated To Remaining Performance Obligations 966.31M EUR.
| Period end | Transaction Price Allocated To Remaining Performance Obligations |
|---|---|
| 2025-12-31 | 771.30M EUR 20-F · filed 2026-02-24 |
| 2024-12-31 | 697.62M EUR 20-F · filed 2026-02-24 |
| 2023-12-31 | 858.08M EUR 20-F · filed 2025-02-25 |
| 2022-12-31 | 966.31M EUR 20-F · filed 2024-02-20 |
| 2021-12-31 | 1.43B EUR 20-F · filed 2023-02-22 |
| 2020-12-31 | 1.92B EUR 20-F · filed 2022-02-22 |
| 2019-12-31 | 1.16B EUR 20-F · filed 2021-02-23 |
| 2018-12-31 | 1.16B EUR 20-F · filed 2021-02-23 |